Lectenz Bio is developing novel products to aid the analysis of glycan biomarkers, furthering their application in human health. The company has developed the Lectenz® and GlycoSense™ platforms for the high-throughput and cost-effective characterization of the glycan profiles of biomolecules. These are key enablers for disease biomarker detection and the development and production of therapeutic biologics and biosimilars in a multibillion dollar market.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):